{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:41:04Z","timestamp":1785361264684,"version":"3.55.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860480"],"award-info":[{"award-number":["81860480"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20232BCJ23034"],"award-info":[{"award-number":["20232BCJ23034"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20224BAB206052"],"award-info":[{"award-number":["20224BAB206052"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20242BAB25494"],"award-info":[{"award-number":["20242BAB25494"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","award":["NDYFYSZ2023046"],"award-info":[{"award-number":["NDYFYSZ2023046"]}],"id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","award":["NDYFY-SZ2023044"],"award-info":[{"award-number":["NDYFY-SZ2023044"]}],"id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","award":["NCUYJSJG-2023-030"],"award-info":[{"award-number":["NCUYJSJG-2023-030"]}],"id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","award":["RSC-0041"],"award-info":[{"award-number":["RSC-0041"]}],"id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbcan.2025.189483","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:51:42Z","timestamp":1761299502000},"page":"189483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Advances in tumor micro-environment and immunotherapy of squamous cell carcinoma of the tongue"],"prefix":"10.1016","volume":"1880","author":[{"given":"Shaopeng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0005","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"International Journal of Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189483_bb0010","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/hed.26177","article-title":"Squamous cell carcinoma of the oral tongue: distinct epidemiological profile disease","volume":"42","author":"Yosefof","year":"2020","journal-title":"Head & Neck"},{"issue":"32","key":"10.1016\/j.bbcan.2025.189483_bb0015","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1200\/JCO.22.02852","article-title":"Randomized phase III study comparing neoadjuvant chemotherapy followed by surgery versus Chemoradiation in stage IB2-IIB cervical Cancer: EORTC-55994","volume":"41","author":"Kenter","year":"2023","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189483_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30097","article-title":"Total neoadjuvant therapy vs standard therapy in locally advanced rectal Cancer: A systematic review and Meta-analysis","volume":"3","author":"Kasi","year":"2020","journal-title":"JAMA Network Open"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189483_bb0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hed.21088","article-title":"Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients","volume":"31","author":"Gonzalez-Garcia","year":"2009","journal-title":"Head & Neck"},{"issue":"7467","key":"10.1016\/j.bbcan.2025.189483_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189483_bb0035","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bbcan.2025.189483_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncology"},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2025.189483_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Seminars in Cancer Biology"},{"issue":"10167","key":"10.1016\/j.bbcan.2025.189483_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"issue":"Pt 3","key":"10.1016\/j.bbcan.2025.189483_bb0055","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.semcancer.2021.11.003","article-title":"Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Seminars in Cancer Biology"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189483_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112429","article-title":"Modification of the tumor microenvironment enhances anti-PD-1 immunotherapy in metastatic melanoma","volume":"14","author":"Shi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbcan.2025.189483_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","article-title":"CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells","volume":"53","author":"Zhou","year":"2016","journal-title":"Oral Oncology"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189483_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12105-020-01229-w","article-title":"Transcriptomic and Immunophenotypic characterization of tumor immune microenvironment in squamous cell carcinoma of the Oral tongue","volume":"15","author":"Chatzopoulos","year":"2021","journal-title":"Head and Neck Pathology"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jop.12885","article-title":"Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue","volume":"48","author":"Kimura","year":"2019","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jop.12172","article-title":"A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma","volume":"43","author":"Zhou","year":"2014","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"7446","key":"10.1016\/j.bbcan.2025.189483_bb0085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120895","article-title":"Macrophages modulate migration and invasion of human tongue squamous cell carcinoma","volume":"10","author":"Piril\u00e4","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0095","doi-asserted-by":"crossref","first-page":"26255","DOI":"10.1038\/s41598-024-76044-2","article-title":"Revealing molecular mechanisms of early-onset tongue cancer by spatial transcriptomics","volume":"14","author":"Patysheva","year":"2024","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ol.2021.12644","article-title":"Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4\/STAT6 in the tumor microenvironment","volume":"21","author":"Kimura","year":"2021","journal-title":"Oncology Letters"},{"key":"10.1016\/j.bbcan.2025.189483_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106458","article-title":"Personal immune profiles: diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence","volume":"143","author":"Daroonpan","year":"2023","journal-title":"Oral Oncology"},{"key":"10.1016\/j.bbcan.2025.189483_bb0110","article-title":"Increased tumor immune microenvironment CD3+ and CD20+ lymphocytes predict a better prognosis in Oral tongue squamous cell carcinoma","volume":"8","author":"Sales De S\u00e1","year":"2020","journal-title":"Frontiers in Cell and Development Biology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbrc.2020.03.022","article-title":"Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8(+) T cells and regulatory T cell-dominance, compared to skin SCC","volume":"526","author":"Kashima","year":"2020","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189483_bb0120","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.bbcan.2025.189483_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.archoralbio.2018.04.015","article-title":"Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma","volume":"92","author":"Liao","year":"2018","journal-title":"Archives of Oral Biology"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189483_bb0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","article-title":"Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe","volume":"15","author":"Aggarwal","year":"2009","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0135","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189483_bb0140","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"21","key":"10.1016\/j.bbcan.2025.189483_bb0145","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","article-title":"Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma","volume":"19","author":"Shi","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0150","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3892\/ol.2016.4184","article-title":"Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinoma","volume":"11","author":"Lao","year":"2016","journal-title":"Oncology Letters"},{"key":"10.1016\/j.bbcan.2025.189483_bb0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6890-14-38","article-title":"Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma","volume":"14","author":"Wirsing","year":"2014","journal-title":"BMC Clinical Pathology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12935-023-03172-6","article-title":"PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy","volume":"24","author":"Xu","year":"2024","journal-title":"Cancer Cell International"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.oraloncology.2012.12.014","article-title":"Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma","volume":"49","author":"Leef","year":"2013","journal-title":"Oral Oncology"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2019.151446","article-title":"Cancer-associated fibroblasts in the tumor microenvironment of tongue carcinoma is a heterogeneous cell population","volume":"121","author":"Vered","year":"2019","journal-title":"Acta Histochemica"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.oraloncology.2010.10.013","article-title":"Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer","volume":"47","author":"Bello","year":"2011","journal-title":"Oral Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0180","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301724R","article-title":"Single-cell RNA sequencing reveals the heterogeneity of epithelial cell and fibroblast cells from non- to metastatic lymph node OTSCC","volume":"38","author":"Song","year":"2024","journal-title":"The FASEB Journal"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0185","first-page":"2484","article-title":"Cancer associated fibroblasts are distinguishable from peri-tumor fibroblasts by biological characteristics in TSCC","volume":"18","author":"Ba","year":"2019","journal-title":"Oncology Letters"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189483_bb0190","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/odi.13306","article-title":"Curcumin suppresses the proliferation and tumorigenicity of Cal27 by modulating cancer-associated fibroblasts of TSCC","volume":"26","author":"Ba","year":"2020","journal-title":"Oral Diseases"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0195","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/acs.jproteome.7b00925","article-title":"Proteomic analysis of Cancer-associated fibroblasts reveals a paracrine role for MFAP5 in human Oral tongue squamous cell carcinoma","volume":"17","author":"Principe","year":"2018","journal-title":"Journal of Proteome Research"},{"issue":"22","key":"10.1016\/j.bbcan.2025.189483_bb0200","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1158\/0008-5472.CAN-16-3453","article-title":"PD-1 expression in head and neck squamous cell carcinomas derives primarily from functionally Anergic CD4(+) TILs in the presence of PD-L1(+) TAMs","volume":"77","author":"Mattox","year":"2017","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12865-024-00597-0","article-title":"Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs","volume":"25","author":"Ahmadvand","year":"2024","journal-title":"BMC Immunology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0210","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.anl.2014.08.007","article-title":"Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue","volume":"41","author":"Ishikawa","year":"2014","journal-title":"Auris Nasus Larynx"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jop.12143","article-title":"\u03b1-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma","volume":"43","author":"Ding","year":"2014","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2015.09.021","article-title":"FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT)","volume":"466","author":"Jiao","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189483_bb0225","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12253-019-00606-3","article-title":"Immunohistochemical study of PD-1\/PD-L1 Axis expression in Oral tongue squamous cell carcinomas: effect of neoadjuvant chemotherapy on local recurrence","volume":"26","author":"Naruse","year":"2020","journal-title":"Pathology Oncology Research"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189483_bb0230","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1158\/0008-5472.CAN-16-2534","article-title":"Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid-derived suppressor cells with a selective inhibitor of PI3Kdelta\/gamma","volume":"77","author":"Davis","year":"2017","journal-title":"Cancer Research"},{"issue":"19","key":"10.1016\/j.bbcan.2025.189483_bb0235","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1158\/1078-0432.CCR-17-3726","article-title":"Clinical relevance and suppressive capacity of human myeloid-derived suppressor cell subsets","volume":"24","author":"Lang","year":"2018","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0240","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-19-2625","article-title":"Inhibition of MDSC trafficking with SX-682, a CXCR1\/2 inhibitor, enhances NK-cell immunotherapy in head and neck Cancer models","volume":"26","author":"Greene","year":"2020","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-022-00866-3","article-title":"Tumor microenvironment: barrier or opportunity towards effective cancer therapy","volume":"29","author":"Tiwari","year":"2022","journal-title":"Journal of Biomedical Science"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0250","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The interplay between extracellular matrix remodeling and Cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0255","first-page":"165","article-title":"Gene expression profiles and protein-protein interaction networks during tongue carcinogenesis in the tumor microenvironment","volume":"17","author":"Sun","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.bbcan.2025.189483_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2024.105925","article-title":"Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma","volume":"161","author":"Thakore","year":"2024","journal-title":"Archives of Oral Biology"},{"key":"10.1016\/j.bbcan.2025.189483_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.771027","article-title":"Controlled fabrication of bioactive microtubes for screening anti-tongue squamous cell migration drugs","volume":"10","author":"Tang","year":"2022","journal-title":"Frontiers in Chemistry"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189483_bb0270","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/hed.27056","article-title":"Relationship of histamine expression with chemokine balance in the tumor microenvironment of squamous cell carcinoma of the tongue","volume":"44","author":"Kimura","year":"2022","journal-title":"Head & Neck"},{"key":"10.1016\/j.bbcan.2025.189483_bb0275","first-page":"3331119","article-title":"Fibroblast growth factor 3 is associated with tongue squamous cell carcinoma: A controlled study","volume":"2022","author":"Zhang","year":"2022","journal-title":"Computational and Mathematical Methods in Medicine"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189483_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30535","article-title":"BRG1 mediates epigenetic regulation of TNF\u03b1-induced CCL2 expression in oral tongue squamous cell carcinoma cells","volume":"125","author":"Xu","year":"2024","journal-title":"Journal of Cellular Biochemistry"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189483_bb0285","first-page":"2111","article-title":"Expression of interleukin-34 in tongue squamous cell carcinoma and its clinical implications","volume":"43","author":"Zhang","year":"2023","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189483_bb0290","first-page":"1073","article-title":"Protein kinase D1 regulates hypoxic metabolism through HIF-1\u03b1 and glycolytic enzymes incancer cells","volume":"40","author":"Chen","year":"2018","journal-title":"Oncology Reports"},{"key":"10.1016\/j.bbcan.2025.189483_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resistance Updates"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0300","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"10212","key":"10.1016\/j.bbcan.2025.189483_bb0305","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0310","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000398","article-title":"Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC immunotherapy resistance taskforce","volume":"8","author":"Kluger","year":"2020","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"6127","key":"10.1016\/j.bbcan.2025.189483_bb0315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglobulin superfamily--CTLA-4","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0320","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"issue":"5256","key":"10.1016\/j.bbcan.2025.189483_bb0325","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"Leach","year":"1996","journal-title":"Science"},{"issue":"10294","key":"10.1016\/j.bbcan.2025.189483_bb0330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189483_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101977","article-title":"Biomarkers for immunotherapy response in head and neck cancer","volume":"84","author":"Gavrielatou","year":"2020","journal-title":"Cancer Treatment Reviews"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0340","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1634\/theoncologist.2019-0244","article-title":"Tumor mutational burden as a predictive biomarker for response to immune checkpoint inhibitors: A review of current evidence","volume":"25","author":"Klempner","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2025.189483_bb0345","article-title":"Tumor mutational burden predicting the efficacy of immune checkpoint inhibitors in colorectal Cancer: A systematic review and Meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0350","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","article-title":"Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: A systematic review and Meta-analysis","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncology"},{"issue":"18","key":"10.1016\/j.bbcan.2025.189483_bb0355","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1158\/1078-0432.CCR-20-0458","article-title":"Tumor mutational burden, toxicity, and response of immune checkpoint inhibitors targeting PD(L)1, CTLA-4, and combination: A Meta-regression analysis","volume":"26","author":"Osipov","year":"2020","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.bbcan.2025.189483_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105179","article-title":"The value and inadequacy of tumor mutation burden on efficacy of immune checkpoint inhibitors in head and neck cancers","volume":"117","author":"Ma","year":"2021","journal-title":"Oral Oncology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0365","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0370","first-page":"54","article-title":"IFN\u03b12b augments immune responses of cisplatin+5-fluorouracil treated tongue squamous cell carcinoma patients--a preliminary study","volume":"136","author":"Mukherjee","year":"2012","journal-title":"The Indian Journal of Medical Research"},{"key":"10.1016\/j.bbcan.2025.189483_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1495722","article-title":"Expression of immune checkpoints (IDO and PD-L1) in oral tongue cancer patients: a 10-year retrospective cohort study in Pakistan","volume":"15","author":"Fatima","year":"2025","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189483_bb0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00262-025-03982-9","article-title":"Stratification of the immunotypes of tongue squamous cell carcinoma to improve prognosis and the response to immune checkpoint inhibitors","volume":"74","author":"Su","year":"2025","journal-title":"Cancer Immunol., Immunother.\u202f: CII."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189483_bb0385","doi-asserted-by":"crossref","first-page":"12225","DOI":"10.18632\/aging.205175","article-title":"Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin","volume":"15","author":"Xin","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2025.189483_bb0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oraloncology.2016.05.002","article-title":"Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer","volume":"58","author":"Davis","year":"2016","journal-title":"Oral Oncology"},{"issue":"19","key":"10.1016\/j.bbcan.2025.189483_bb0395","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.bbcan.2025.189483_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104723","article-title":"Targeting tumor-associated macrophages in head and neck squamous cell carcinoma","volume":"106","author":"Li","year":"2020","journal-title":"Oral Oncology"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189483_bb0405","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00005-017-0492-4","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: current knowledge and future perspectives","volume":"66","author":"Ibanez-Vea","year":"2018","journal-title":"Archivum Immunologiae et Therapiae Experimentalis (Warsz)"},{"issue":"13","key":"10.1016\/j.bbcan.2025.189483_bb0410","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/1078-0432.CCR-22-0159","article-title":"A paradigm of Cancer immunotherapy based on 2-[18F]FDG and anti-PD-L1 mAb combination to enhance the antitumor effect","volume":"28","author":"Wen","year":"2022","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0415","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1471-4906(03)00072-3","article-title":"Tolerance, DCs and tryptophan: much ado about IDO","volume":"24","author":"Grohmann","year":"2003","journal-title":"Trends in Immunology"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0420","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/cmi.2017.143","article-title":"IDO1 in cancer: a Gemini of immune checkpoints","volume":"15","author":"Zhai","year":"2018","journal-title":"Cellular & Molecular Immunology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0425","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13402-017-0336-6","article-title":"Histamine H(4) receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report","volume":"40","author":"Salem","year":"2017","journal-title":"Cellular Oncology (Dordrecht)"},{"key":"10.1016\/j.bbcan.2025.189483_bb0430","doi-asserted-by":"crossref","first-page":"1199513","DOI":"10.3389\/fimmu.2023.1199513","article-title":"Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix","volume":"14","author":"Flies","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0435","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2353\/ajpath.2009.081110","article-title":"A novel organotypic model mimics the tumor microenvironment","volume":"175","author":"Nurmenniemi","year":"2009","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061399","article-title":"The role of Cancer-associated fibroblasts in tumor progression","volume":"13","author":"Joshi","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189483_bb0445","doi-asserted-by":"crossref","DOI":"10.4161\/onci.25563","article-title":"Cancer-associated fibroblasts and macrophages: friendly conspirators for malignancy","volume":"2","author":"Chiarugi","year":"2013","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189483_bb0450","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Reports"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0455","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0460","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.4049\/jimmunol.1102757","article-title":"Substrate rigidity regulates human T cell activation and proliferation","volume":"189","author":"O\u2019Connor","year":"2012","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0465","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","article-title":"Collagen density regulates the activity of tumor-infiltrating T cells","volume":"7","author":"Kuczek","year":"2019","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189483_bb0470","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1111\/febs.15566","article-title":"Matrix stiffness-mediated effects on macrophages polarization and their LOXL2 expression","volume":"288","author":"Xing","year":"2021","journal-title":"The FEBS Journal"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0475","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2017-07-740993","article-title":"PD-1 expression and clinical PD-1 blockade in B-cell lymphomas","volume":"131","author":"Xu-Monette","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0480","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41591-022-02189-0","article-title":"Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial","volume":"29","author":"Cascone","year":"2023","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189483_bb0485","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13014-023-02342-0","article-title":"Advancements of radiotherapy for recurrent head and neck cancer in modern era","volume":"18","author":"Zhang","year":"2023","journal-title":"Radiation Oncol. (London, England)."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189483_bb0495","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189483_bb0500","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/1078-0432.CCR-21-3351","article-title":"Phase II clinical trial of neoadjuvant and adjuvant Pembrolizumab in Resectable local-regionally advanced head and neck squamous cell carcinoma","volume":"28","author":"Wise-Draper","year":"2022","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.bbcan.2025.189483_bb0505","doi-asserted-by":"crossref","DOI":"10.1177\/11795549221120708","article-title":"Igniting Hope for tumor immunotherapy: promoting the \u201chot and cold\u201d tumor transition","volume":"16","author":"Wei","year":"2022","journal-title":"Clin Med Insights Oncol."},{"issue":"21","key":"10.1016\/j.bbcan.2025.189483_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218363","article-title":"Lactic acid and an acidic tumor microenvironment suppress anticancer immunity","volume":"21","author":"Wang","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0515","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun (Lond)."},{"issue":"7528","key":"10.1016\/j.bbcan.2025.189483_bb0520","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0525","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0530","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-020-03448-1","article-title":"A review of glioblastoma immunotherapy","volume":"151","author":"Medikonda","year":"2021","journal-title":"Journal of Neuro-Oncology"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189483_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070925","article-title":"Cathepsin K is present in invasive oral tongue squamous cell carcinoma in vivo and in vitro","volume":"8","author":"Bitu","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189483_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091332","article-title":"Photodynamic therapy review: principles, photosensitizers, applications, and future directions","volume":"13","author":"Correia","year":"2021","journal-title":"Pharmaceutics"},{"issue":"38","key":"10.1016\/j.bbcan.2025.189483_bb0545","first-page":"26140","article-title":"Mitochondria-targeting AIEgens as Pyroptosis inducers for boosting type-I photodynamic therapy of tongue squamous cell carcinoma","volume":"18","author":"Peng","year":"2024","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189483_bb0550","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.7150\/thno.32867","article-title":"Ferroptosis promotes photodynamic therapy: supramolecular photosensitizer-inducer Nanodrug for enhanced Cancer treatment","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189483_bb0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12967-016-0828-6","article-title":"Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma","volume":"14","author":"Eckert","year":"2016","journal-title":"Journal of Translational Medicine"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189483_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185085","article-title":"The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand","volume":"12","author":"Epstein","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0565","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Molecular Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"Kim","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.bbcan.2025.189483_bb0575","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Current Opinion in Immunology"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0580","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4049\/jimmunol.1800827","article-title":"From Cancer immune surveillance to Cancer Immunoediting: birth of modern Immuno-oncology","volume":"201","author":"Fridman","year":"2018","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.bbcan.2025.189483_bb0585","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2018.01605","article-title":"Diverse roles of mitochondria in immune responses: novel insights into Immuno-metabolism","volume":"9","author":"Angajala","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.bbcan.2025.189483_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2020.585710","article-title":"Hypoxic transformation of immune cell metabolism within the microenvironment of Oral cancers","volume":"1","author":"Chaudhary","year":"2020","journal-title":"Frontiers in Oral Health"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0595","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trecan.2021.10.004","article-title":"Revisiting the HIF switch in the tumor and its immune microenvironment","volume":"8","author":"Cowman","year":"2022","journal-title":"Trends Cancer."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189483_bb0600","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.joca.2013.01.007","article-title":"Hypoxia-induced collagen crosslinking as a mechanism for enhancing mechanical properties of engineered articular cartilage","volume":"21","author":"Makris","year":"2013","journal-title":"Osteoarthritis and Cartilage"},{"issue":"45","key":"10.1016\/j.bbcan.2025.189483_bb0605","doi-asserted-by":"crossref","first-page":"E4832","DOI":"10.1073\/pnas.1414271111","article-title":"Developing functional musculoskeletal tissues through hypoxia and lysyl oxidase-induced collagen cross-linking","volume":"111","author":"Makris","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0610","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/jcb.27681","article-title":"Extracellular matrix (ECM) stiffness and degradation as cancer drivers","volume":"120","author":"Najafi","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189483_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115257","article-title":"Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors","volume":"28","author":"Laghezza","year":"2020","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0620","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13543776.2021.1874345","article-title":"Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016-2020)","volume":"31","author":"Ban","year":"2021","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0625","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2010.06.007","article-title":"Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis","volume":"48","author":"Lynch","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bbcan.2025.189483_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134822","article-title":"MMP-mediated modulation of ECM environment during axonal growth and NMJ development","volume":"724","author":"Chan","year":"2020","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.bbcan.2025.189483_bb0635","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","article-title":"Emerging roles of ECM remodeling processes in cancer","volume":"62","author":"Mohan","year":"2020","journal-title":"Seminars in Cancer Biology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0640","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s42003-021-02539-7","article-title":"Causal contributors to tissue stiffness and clinical relevance in urology","volume":"4","author":"Martinez-Vidal","year":"2021","journal-title":"Communications Biology"},{"issue":"7693","key":"10.1016\/j.bbcan.2025.189483_bb0645","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189483_bb0650","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ceb.2015.06.006","article-title":"The regulation of immune cell trafficking by the extracellular matrix","volume":"36","author":"Hallmann","year":"2015","journal-title":"Current Opinion in Cell Biology"},{"issue":"7","key":"10.1016\/j.bbcan.2025.189483_bb0655","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv085","article-title":"Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer","volume":"107","author":"Yates","year":"2015","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189483_bb0660","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI127515","article-title":"Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy","volume":"130","author":"Sharma","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189483_bb0665","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1021\/acsnano.0c00417","article-title":"Photothermal depletion of Cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma","volume":"14","author":"Nicolas-Boluda","year":"2020","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189483_bb0670","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal Cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:24:52Z","timestamp":1781065492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0304419X25002252"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189483","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in tumor micro-environment and immunotherapy of squamous cell carcinoma of the tongue","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189483"}}